hepatic arterial blood flow index is associated with the degree of liver fibrosis in patients with chronic hepatitis b virus infection

Background: liver fibrosis due to hepatitis b virus (hbv) infection is an important public health concern worldwide. an accurate assessment of liver fibrosis is crucial for the identification of susceptible patients to severe clinical conditions and selection of treatment for patients with chronic hepatitis b (chb) infection. today, the development of simple, accurate, cost-effective, and non-invasive liver fibrosis tests is essential in clinical practice. methods: according to liver biopsy as the reference standard, we compared the efficacy of hepatic arterial blood flow index (hbi) versus liver stiffness measurement (lsm), aspartate aminotransferase-to-platelet count ratio index (apri), and fibrosis index based on 4 factors (fib-4) to predict various degrees of liver fibrosis among 87 patients with chb infection. results: spearman’s rank correlation coefficient of hbi versus the degree of liver fibrosis, according to the metavir scoring system, was 0.672 (p < 0.001). the area under the receiver operating characteristic curve (auroc) of hbi (0.884; 95% ci: 0.806 - 0.961; p = 0.000) was greater than that of lsm (0.807; 95% ci: 0.703 - 0.912; p = 0.00), apri (0.684; 95% ci: 0.556 - 0.812; p = 0.009), and fib-4 (0.757; 95% ci: 0.641 - 0.873; p = 0.000) for the diagnostic analysis of significant liver fibrosis (≥ f2); similar results were obtained for the prediction of other liver fibrosis stages. conclusions: the present findings shed new light on the association of hbi with the degree of liver fibrosis in patients with chb infection. hepatic arterial perfusion scintigraphy (haps) with the measurement of hbi is a promising diagnostic method of liver fibrosis stage, which can guide therapy in chb patients, although further large-scale studies are needed.